Melanoma
Case Letter
Nonmalignant Cutaneous Findings Associated With Vemurafenib
Original Research
Perceptions of Tanning Risk Among Melanoma Patients With a History of Indoor Tanning
A new US Food and Drug Administration (FDA) regulation classified tanning beds as class II, requiring indoor tanning facilities to inform users of...
News
FDA expands approval of nivolumab for melanoma treatment
Nivolumab was approved for the adjuvant treatment of melanoma patients with involvement of lymph nodes or in patients with metastatic disease who...
Conference Coverage
First-in-class glutaminase inhibitor combats anti-PD-1/PD-L1 resistance
NATIONAL HARBOR, MD. – Responses in melanoma patients who were progressing on nivolumab at study entry and who were refractory to multiple prior...
Commentary
The Effects of Sunscreen on Marine Environments
News
Breakthrough cancer gene assay approved, CMS proposes coverage
FDA approves first breakthrough-designated, next-generation sequencing assay that can detect genetic mutations in 324 genes and two genomic...
From the Journals
Gut bacteria influenced response to checkpoint inhibitors
“An obvious next step is to run a clinical trial to test the hypothesis that by modulating the microbiome, you can actually enhance responses to...
From the Journals
Neoantigen profiling predicts response to immunotherapy
In antitumor immunity and immunotherapy, quality and fitness count.Specifically, the quality and fitness of neoantigens – tumor-specific mutated...
From the Journals
T-VEC improves melanoma response without toxicity increase
Objective responses were seen in 39% of melanoma patients receiving T-VEC/ipilimumab, compared with 18% receiving ipilimumab alone.
Tips
Debunking Actinic Keratosis Myths: Are Patients With Darker Skin At Risk for Actinic Keratoses?
Skin of Color
Assessing the Effectiveness of Knowledge-Based Interventions in Increasing Skin Cancer Awareness, Knowledge, and Protective Behaviors in Skin of Color Populations
Skin of color (SOC) populations (ie, blacks, Hispanics, Asians) are at a notably higher risk for mortality from skin cancers such as melanoma than...